Diabetes Leadership Edge: Module 4 - Pharmacotherapy Part 1: Treatment Algorithm and Non-Insulin Therapies
This interactive module is four of seven designed to prepare PAs to effectively care for patients affected by diabetes and is the start of the discussion on pharmacotherapy and focuses on current standards of practice in type 2 diabetes management that ends in module 5, Pharmocotherapy Part 2: Insulin Therapy and Challenging Cases. This activity is part of AAPA’s curriculum known as Diabetes Leadership Edge.
Learning ObjectivesAt the conclusion of this activity, participants should be able to:
- Outline an overall approach to treating type 2 diabetes, consistent with the ADA Standards of Medical Care in Diabetes and the AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm.
- Set appropriate patient centered A1C targets based on clinical characteristics.
- Identify how clinical inertia contributes to patients spending extended periods of time out of glycemic control and outline strategies to overcome it.
- Review oral agents used in the management of type 2 diabetes including mechanism of action and general principles of use.
- Provide a rationale for choosing a second agent based on patient characteristics and specific clinical conditions, and on what can be achieved by the addition of the agent in terms of glucose control and other potential benefits.
- Review potential adverse events and approaches to managing them when they occur.